ArticleBone marrow transplantation2023

Propensity score matching analysis comparing the efficacy of Ruxolitinib to historical controls in second-line or beyond treatment for chronic GvHD after steroid failure.

Igor Novitzky-Basso et al.PubMed ↗Publisher ↗

No numbers read from the abstract.